- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
195
Companies with a Value score of at least 3, ordered by Value score
195 companies
Thermo Fisher Scientific
Market Cap: US$176.7b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
0R0H
US$468.43
7D
-2.1%
1Y
-23.8%
Formycon
Market Cap: €911.0m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYBD
€63.30
7D
0%
1Y
-11.1%
Marinomed Biotech
Market Cap: €19.3m
A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.
MARIV
€21.20
7D
0%
1Y
n/a
H. Lundbeck
Market Cap: DKK 33.5b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUNAC
DKK 34.25
7D
0%
1Y
9.4%
Innate Pharma
Market Cap: €248.2m
Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.
IPHP
€3.31
7D
0%
1Y
n/a
Boiron
Market Cap: €937.6m
Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.
BOIP
€50.60
7D
0%
1Y
14.7%
Saniona
Market Cap: SEK 1.7b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANIOS
SEK 13.54
7D
0%
1Y
n/a
Swedish Orphan Biovitrum
Market Cap: SEK 96.7b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBIS
SEK 275.30
7D
0%
1Y
-13.3%
Valneva
Market Cap: €738.4m
A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.
VLAP
€4.24
7D
9.1%
1Y
n/a
Evotec
Market Cap: €1.1b
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVTD
€5.94
7D
0%
1Y
n/a
Faes Farma
Market Cap: €1.3b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide.
0K9H
€4.22
7D
1.4%
1Y
15.3%
Genmab
Market Cap: DKK 115.0b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMABC
DKK 1,852.50
7D
5.3%
1Y
15.2%
Saniona
Market Cap: SEK 1.6b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
0RQJ
SEK 11.58
7D
3.6%
1Y
n/a
Kuros Biosciences
Market Cap: CHF 927.5m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURNz
CHF 24.00
7D
1.6%
1Y
31.1%
Centessa Pharmaceuticals
Market Cap: US$3.1b
A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.
0ACX
US$23.68
7D
5.9%
1Y
50.6%
Genfit
Market Cap: €154.7m
A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.
0QT6
€3.11
7D
-15.2%
1Y
-38.3%
10x Genomics
Market Cap: US$1.5b
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
0A88
US$12.00
7D
-8.6%
1Y
-45.0%
Incyte
Market Cap: US$16.4b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
0J9P
US$83.94
7D
-2.0%
1Y
29.7%
BioNTech
Market Cap: US$24.0b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
0A3M
US$99.35
7D
2.8%
1Y
-15.5%
MDxHealth
Market Cap: €70.9m
A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
0O8G
€3.02
7D
0%
1Y
6.3%
Hansa Biopharma
Market Cap: SEK 2.9b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSAS
SEK 24.11
7D
0%
1Y
n/a
Idorsia
Market Cap: CHF 777.6m
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIAZ
CHF 3.73
7D
-9.7%
1Y
142.7%
Verastem
Market Cap: US$565.6m
A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.
0LOV
US$8.88
7D
-7.5%
1Y
228.2%
Orexo
Market Cap: SEK 1.0b
A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.
0H19
SEK 29.10
7D
6.6%
1Y
105.8%
Amgen
Market Cap: €150.3b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGD
€243.85
7D
4.4%
1Y
-16.8%
Revvity
Market Cap: US$9.8b
Provides health sciences solutions, technologies, and services.
0KHE
US$84.20
7D
-3.7%
1Y
-33.4%
Viridian Therapeutics
Market Cap: US$1.6b
Engages in discovering, developing, and commercializing treatments for serious and rare diseases.
0K1R
US$19.60
7D
2.6%
1Y
-16.0%
Tecan Group
Market Cap: CHF 2.0b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
0QLN
CHF 155.01
7D
-2.2%
1Y
-43.4%
Ionis Pharmaceuticals
Market Cap: US$10.2b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
0JDI
US$63.59
7D
3.5%
1Y
56.2%
Novartis
Market Cap: CHF 187.7b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVNZ
CHF 91.30
7D
1.6%
1Y
8.4%
SKAN Group
Market Cap: CHF 1.2b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKANZ
CHF 54.90
7D
-5.3%
1Y
-30.7%
PolyPeptide Group
Market Cap: CHF 801.7m
Operates as a contract development and manufacturing company in Europe, the United States, and India.
PPGNZ
CHF 24.30
7D
-5.9%
1Y
-19.9%
Animalcare Group
Market Cap: UK£172.5m
Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.
ANCR
UK£2.50
7D
0%
1Y
5.0%
Roche Holding
Market Cap: US$223.1b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
0TDF
US$41.05
7D
-1.0%
1Y
3.2%
Zoetis
Market Cap: US$62.8b
Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.
0M3Q
US$141.39
7D
-4.0%
1Y
-27.0%
Roche Holding
Market Cap: CHF 223.1b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
0QQ6
CHF 273.00
7D
-0.7%
1Y
-5.9%